Tailored Information About the Coronavirus for Patients With Chronic Kidney Disease
NCT ID: NCT04854382
Last Updated: 2022-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
215 participants
INTERVENTIONAL
2021-04-14
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
What Works to Get the Elderly Vaccinated Against COVID-19? Experimental Evidence From India
NCT04870593
Message Testing for CKD
NCT05462158
Nationwide Utilization of Danish Government Electronic Letter System for Increasing Guideline-directed Medical Therapy in Chronic Kidney Disease
NCT06300086
Piloting an Intervention for Improving Treatment Adherence
NCT02250235
A Randomized Controlled Trial of a Pre-Transplant Education Intervention
NCT03633136
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Tailored information about coronavirus using information videos followed by a teach-back procedure
Tailored information
Tailored information about coronavirus for patients with chronic kidney disease by information videos followed by a teach back procedure
Control group
Controls have access to information videos, but do not receive the teach-back procedure (the intervention)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tailored information
Tailored information about coronavirus for patients with chronic kidney disease by information videos followed by a teach back procedure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ivar Anders Eide
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ivar Anders Eide
Consultant Doctor / Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ivar A Eide, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Akershus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Akershus University Hospital
Lørenskog, Akershus, Norway
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REK 144084/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.